These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12434665)

  • 21. [Prognostic factors of common epithelial ovarian cancer treated by surgery and cisplatin based combination chemotherapy].
    Sasaki H; Ochiai K; Terashima Y; Mochizuki S; Soda T; Nishimura H; Yakushiji M; Hirabayashi M
    Gan No Rinsho; 1989 Oct; 35(13):1615-20. PubMed ID: 2585733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Current classification of malignant tumours in gynecological oncology--part II].
    Sehnal B; Driák D; Kmonícková E; Dvorská M; Hosová M; Citterbart K; Halaska M; Kolarík D
    Ceska Gynekol; 2011 Oct; 76(5):360-6. PubMed ID: 22132636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis.
    Sherman ME; Mink PJ; Curtis R; Cote TR; Brooks S; Hartge P; Devesa S
    Cancer; 2004 Mar; 100(5):1045-52. PubMed ID: 14983501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epithelial ovarian tumors in the reproductive age group: age is not an independent prognostic factor.
    Massi D; Susini T; Savino L; Boddi V; Amunni G; Colafranceschi M
    Cancer; 1996 Mar; 77(6):1131-6. PubMed ID: 8635134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinically apparent early stage invasive epithelial ovarian carcinoma: should all be treated similarly?
    Le T; Krepart GV; Lotocki RJ; Heywood MS
    Gynecol Oncol; 1999 Aug; 74(2):252-4. PubMed ID: 10419740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Current classification of malignant tumours in gynecological oncology--part I].
    Sehnal B; Driák D; Kmonícková E; Dvorská M; Hosová M; Citterbart K; Halaska M; Kolarík D
    Ceska Gynekol; 2011 Sep; 76(4):279-84. PubMed ID: 22026069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for depression in survivors of metastatic ovarian cancer in a programme of palliative cancer care.
    Slovacek L; Slanska I; Slovackova B; Petera J; Filip S; Priester P; Kopecky J; Jebavy L
    Bratisl Lek Listy; 2009; 110(10):655-9. PubMed ID: 20017460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Borderline ovarian tumors: an epidemiologic, diagnostic, prognostic and therapeutic study. Apropos of 20 cases reported at the Saint-Antoine Maternity Hospital].
    Faguer C; Maghioracos P; Marpeau L; Giorgi H
    Sem Hop; 1983 Feb; 59(8):509-12. PubMed ID: 6302892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prognosis factors in epithelial tumors of the ovary].
    Frigerio L; Ferrari A; Busci L; Pirondini A; Garsia S; Caldarella M; Pifarotti G
    Ann Ostet Ginecol Med Perinat; 1989; 110(6):283-9. PubMed ID: 2639615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Annual report of Gynecologic Oncology Committee, Japan Society of Obstetrics and Gynecology, 2013.
    Aoki D
    J Obstet Gynaecol Res; 2014 Feb; 40(2):338-48. PubMed ID: 24472052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Active cellular immunotherapy of ovarian cancer using dendritic cells].
    Brtnicky T; Podrazil M; Bartunkova J; Spíšek R; Rob L
    Ceska Gynekol; 2012 Jun; 77(3):215-20. PubMed ID: 22779721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Epithelial advanced ovarian carcinoma in the central region of Tunisia: therapeutic results and prognostic factors on 104 patients].
    Ben Fatma L; Hochlef M; Gharbi O; Landolsi A; Limam S; Chabchoub I; Cherif N; Bouguizene S; Yacoubi T; Bibi M; Khairi H; Ben Ahmed S
    Bull Cancer; 2006 Dec; 93(12):1233-9. PubMed ID: 17182378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Epithelial ovarian cancers (advanced stage)].
    Spano JP; Lucchi E; Sezeur A; Lhomme C
    Bull Cancer; 1998 Nov; Suppl 2():5-23. PubMed ID: 9917549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prognostic factors in patients with stage I epithelial ovarian cancer].
    Wen HW; Liu SW
    Zhonghua Fu Chan Ke Za Zhi; 1994 Apr; 29(4):235-7, 255. PubMed ID: 8082450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Multidisciplinary treatment of recurrent epithelial ovarian carcinoma and prognostic analysis].
    Huang X; Cai SM; Tang J; Li ZT; Zang RY
    Zhonghua Fu Chan Ke Za Zhi; 2004 Sep; 39(9):602-5. PubMed ID: 15498187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
    Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Proteomics and biomarkers for detection of ovarian cancer].
    Kacerovský M; Tambor V; Lenco J; Tosner J
    Ceska Gynekol; 2009 Jun; 74(3):163-70. PubMed ID: 19642513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical study on the treatment of malignant ovarian tumor--particularly the clinical management of dysgerminoma and common epithelial carcinoma.
    Yakushiji M; Abe M; Tsunawaki A; Nishimura H; Kato T
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Nov; 32(11):1879-87. PubMed ID: 7240840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Borderline ovarian tumors--10-year clinical series and literature review].
    Freitag P; Jancárková N; Fischerová D; Cibula D; Zivný J
    Ceska Gynekol; 2004 Jul; 69(4):278-82. PubMed ID: 15369246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of recurrent ovarian cancer].
    Robová H; Rob L; Pluta M; Halaska M; Chmel R
    Ceska Gynekol; 2009 Dec; 74(6):464-8. PubMed ID: 21246797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.